Insider trades
Dominick Colangelo, Director of Trevi Therapeutics TRVI, has filed 0 purchases and 33 sales on the open market. The latest trade was on 06/03.
Dominick Colangelo
Director
- Company
- Trevi Therapeutics TRVI
- First filing
- 23/01/12
- Trades
- 164 trades
- Buys / sales
- 0 / 33
- 12-month net buying
- No record
- Last trade
- 06/03
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
VCEL | Open-market sale10b5-1 plan | 25/05/14–25/05/15 | 25/05/16 | 28,125 sh2 trades | $41.89avg. | $1,178,155.89 | −9.7% |
VCEL | Open-market sale10b5-1 plan | 25/04/09–25/04/10 | 25/04/11 | 49,700 sh2 trades | $41.50avg. | $2,062,550 | −16.0% |
VCEL | Open-market sale10b5-1 plan | 25/03/12–25/03/13 | 25/03/14 | 53,183 sh2 trades | $46.04avg. | $2,448,810.97 | −17.0% |
VCEL | Open-market sale10b5-1 plan | 24/11/13–24/11/14 | 24/11/15 | 35,000 sh2 trades | $54.75avg. | $1,916,250 | −13.7% |
VCEL | Open-market sale10b5-1 plan | 24/10/16–24/10/17 | 24/10/18 | 35,000 sh2 trades | $40.86avg. | $1,430,100 | −13.7% |
VCEL | Open-market sale10b5-1 plan | 24/09/11–24/09/12 | 24/09/13 | 35,000 sh2 trades | $43.64avg. | $1,527,225 | −13.7% |
VCEL | Open-market sale10b5-1 plan | 24/08/14–24/08/15 | 24/08/16 | 35,000 sh2 trades | $45.71avg. | $1,599,675 | −13.7% |
VCEL | Open-market sale10b5-1 plan | 24/07/17–24/07/18 | 24/07/19 | 35,000 sh2 trades | $51.48avg. | $1,801,625 | −13.7% |
VCEL | Open-market sale10b5-1 plan | 24/06/12–24/06/13 | 24/06/14 | 35,000 sh2 trades | $43.61avg. | $1,526,350 | −13.7% |
VCEL | Open-market sale10b5-1 plan | 24/05/15–24/05/16 | 24/05/17 | 35,000 sh2 trades | $48.76avg. | $1,706,600 | −13.7% |
VCEL | Open-market sale10b5-1 plan | 24/04/17–24/04/18 | 24/04/19 | 35,000 sh2 trades | $45.53avg. | $1,593,550 | −15.2% |
VCEL | Open-market sale10b5-1 plan | 24/03/13–24/03/14 | 24/03/15 | 35,000 sh2 trades | $44.35avg. | $1,552,075 | −15.2% |
VCEL | Open-market sale10b5-1 plan | 24/02/14–24/02/15 | 24/02/16 | 35,000 sh2 trades | $47.92avg. | $1,677,200 | −16.7% |
VCEL | Open-market sale10b5-1 plan | 24/01/17–24/01/18 | 24/01/19 | 33,452 sh2 trades | $38.27avg. | $1,280,375.3 | −16.4% |
VCEL | Open-market sale10b5-1 plan | 23/12/13–23/12/14 | 23/12/15 | 24,000 sh2 trades | $35.58avg. | $853,800 | −12.4% |
VCEL | Open-market sale10b5-1 plan | 23/12/06–23/12/07 | 23/12/08 | 24,397 sh2 trades | $34.14avg. | $832,908.71 | −12.1% |
VericelVCEL | Open-market sale | 23/01/10 | 23/01/12 | 39,938 sh | $27.13 | $1,083,517.94 | −20.3% |
